Zenith Epigenetics Corp

Resverlogix Inc is a late-stage clinical biotechnology company based in San Francisco, CA. Founded in 2001, the company focuses on developing safe and effective therapeutics for patients suffering from chronic illnesses. With a strong emphasis on epigenetics, Resverlogix is a global leader in the development of a new class of drugs designed to regulate disease-associated epigenetics, particularly in cardiovascular diseases. Resverlogix's flagship drug, apabetalone, has received Breakthrough Therapy designation from the US FDA, positioning the company at the forefront of modern medicine. Through their science programs and global Phase 3 clinical trial, BETonMACE, Resverlogix aims to provide innovative solutions to key stakeholders, including payer groups, and improve the lives of patients with high unmet medical needs.Generated from the website

INDICAL Inc is a global biotech company with over two decades of experience in developing and commercializing innovative diagnostic solutions for veterinary applications. They offer a wide range of products, including sample preparation instruments, assays, and reagents for various animal species, such as ruminants, swine, avian poultry, equine, and companion animals. INDICAL is committed to improving diagnostics for better animal and human health. With a global network covering 169 countries and 75 commercial partners, INDICAL is known for its expertise in providing reliable results and certainty for the future. They prioritize customer satisfaction and work closely with customers to achieve technology and workflow excellence. INDICAL also actively participates in conferences and events worldwide, sharing their knowledge and supporting veterinary practice, research, and science.Generated from the website

Akero Therapeutics, based in San Francisco, is a leading cardio-metabolic biotechnology company focused on developing innovative treatments for non-alcoholic steatohepatitis (NASH). The company's mission is to create transformational therapies that address the unmet medical needs of individuals suffering from NASH, a serious liver condition with limited treatment options. Generated from their website's infomation